Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "Global"

4792 News Found

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network
Hospitals | April 20, 2026

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network

The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.


UICC report flags air pollution as major multi-cancer risk
Healthcare | April 20, 2026

UICC report flags air pollution as major multi-cancer risk

The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%


C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools
Healthcare | April 20, 2026

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits


Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
Drug Approval | April 20, 2026

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation


Precision BioSciences expands Hepatitis B gene editing trial into France and Romania
Biotech | April 20, 2026

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania


Merck bags EU nod for infant RSV protection in major public health milestone
News | April 19, 2026

Merck bags EU nod for infant RSV protection in major public health milestone

ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose


ANRF CEO calls for excellence-led innovation at SRMIST Research Day
R&D | April 18, 2026

ANRF CEO calls for excellence-led innovation at SRMIST Research Day

Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe


Experts endorse low-sodium salt substitutes to cut India’s hypertension burden
Public Health | April 18, 2026

Experts endorse low-sodium salt substitutes to cut India’s hypertension burden

Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk